更正：基于代谢组学的急性呼吸窘迫综合征预测生物标志物模型：临床低氧血症的系统测量
Correction: Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.
出版信息
PLoS One. 2018 Feb 21;13(2):e0193474. doi: 10.1371/journal.pone.0193474. eCollection 2018.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0187545.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0187545。]
相似文献
1
Correction: Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.更正：基于代谢组学的急性呼吸窘迫综合征预测生物标志物模型：临床低氧血症的系统测量
PLoS One. 2018 Feb 21;13(2):e0193474. doi: 10.1371/journal.pone.0193474. eCollection 2018.
2
Correction: pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.更正：磷酸化黏着斑激酶酪氨酸397（pFAK-Y397）过表达作为转移性骨肉瘤患者的预后和预测生物标志物。
PLoS One. 2017 Nov 29;12(11):e0188991. doi: 10.1371/journal.pone.0188991. eCollection 2017.
3
Correction: Metabolomics analysis: Finding out metabolic building blocks.更正：代谢组学分析：探寻代谢基石。
PLoS One. 2017 Oct 12;12(10):e0186626. doi: 10.1371/journal.pone.0186626. eCollection 2017.
4
Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.更正：根据HIV感染阶段、疾病进展速度、病毒血症水平及治疗免疫反应的血浆代谢组学生物标志物
PLoS One. 2017 Feb 24;12(2):e0173164. doi: 10.1371/journal.pone.0173164. eCollection 2017.
5
Correction: An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula.更正：基于经验生物标志物的常染色体隐性多囊肾病模型中囊肿指数计算器——涅托-纳拉扬公式。
PLoS One. 2016 Dec 9;11(12):e0168319. doi: 10.1371/journal.pone.0168319. eCollection 2016.
6
Correction: Bioassay- and metabolomics-guided screening of bioactive soil actinomycetes from the ancient city of Ihnasia, Egypt.更正：对来自埃及伊赫纳西亚古城的具有生物活性的土壤放线菌进行生物测定和代谢组学引导的筛选。
PLoS One. 2020 Feb 3;15(2):e0228901. doi: 10.1371/journal.pone.0228901. eCollection 2020.
7
Correction: challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.更正：开发血管生成抑制剂有效生物标志物面临的挑战：莫替沙尼的经验。
PLoS One. 2015 Mar 26;10(3):e0121162. doi: 10.1371/journal.pone.0121162. eCollection 2015.
8
Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.更正：HP1β是乳腺癌预后和PARP抑制剂治疗的生物标志物。
PLoS One. 2015 Apr 13;10(4):e0124853. doi: 10.1371/journal.pone.0124853. eCollection 2015.
9
Correction: Detection of a Serum Siderophore by LC-MS/ MS as a Potential Biomarker of Invasive Aspergillosis.更正：通过液相色谱-质谱联用技术检测血清铁载体作为侵袭性曲霉病的潜在生物标志物
PLoS One. 2016 May 10;11(5):e0155451. doi: 10.1371/journal.pone.0155451. eCollection 2016.
10
Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?更正：CC趋化因子配体18的血清水平是否为预测放射性肺损伤（RILT）的生物标志物？
PLoS One. 2018 Jan 25;13(1):e0192058. doi: 10.1371/journal.pone.0192058. eCollection 2018.
本文引用的文献
1
Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.基于代谢组学的急性呼吸窘迫综合征预测生物标志物模型：临床低氧血症的系统测量
PLoS One. 2017 Nov 2;12(11):e0187545. doi: 10.1371/journal.pone.0187545. eCollection 2017.
Zotero 插件